SCHEMBL9266828

SCHEMBL9266828

COc1ccc(C(O)CCCCCn2ccnc2)c(Cl)c1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ ADRA2C P18825 1/20 0.51
▸ KMT2A Q03164 4/20 0.50
▸ MEN1 O00255 2/20 0.50
▸ ATM Q13315 1/20 0.50
▸ IDO1 P14902 2/20 0.48
▸ KDM4E B2RXH2 2/20 0.47
▸ LMNA P02545 2/20 0.47
▸ GAA P10253 1/20 0.47
▸ TP53 P04637 2/20 0.46
▸ MAPK1 P28482 2/20 0.46
▸ ALDH1A1 P00352 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ HTT P42858 2/20 0.46
▸ SMN1; SMN2 Q16637 1/20 0.46
▸ TBXAS1 P24557 3/20 0.45
▸ QPCT Q16769 2/20 0.45
▸ TSHR P16473 1/20 0.45
▸ MAOB P27338 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8540598 0.88 QPCT (0.53) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL9258888 0.85 MEN1 (0.59) ADRA2CKMT2AMEN1TP53MAPK1
SCHEMBL8585641 0.81 MEN1 (0.60) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL9262602 0.81 MEN1 (0.60) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL9869219 0.81 KMT2A (0.51) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL10927284 0.80 ADRA2C (0.74) ADRA2CKMT2AMEN1IDO1LMNA
Hydrochloric Acid SCHEMBL8590994 0.80 KMT2A (0.50) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL10700909 0.79 KMT2A (0.54) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL9267414 0.78 MEN1 (0.72) KMT2AMEN1ATMKDM4ELMNA
SCHEMBL9260580 0.78 MEN1 (0.72) KMT2AMEN1ATMKDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0274867-A2 Pharmaceutically active compounds SCHERING CORPORATION (US) 1988-07-20 — — EP claimed
US-5459144-A Enterovirus and rhinovirus antiviral, antiinflammatory and antagonist of platelet activating factor SCHERING CORPORATION (US) 1995-10-17 — — US disclosed
US-5272167-A Pharmaceutically active compounds SCHERING CORPORATION (US) 1993-12-21 — — US disclosed
EP-0560407-A1 Pharmaceutically active compounds SCHERING CORPORATION (US) 1993-09-15 — — EP disclosed
WO-1991000858-A1 PHARMACEUTICALLY ACTIVE COMPOUNDS SCHERING CORPORATION (US) 1991-01-24 — — WO disclosed
EP-0407217-A1 Pharmaceutically active compounds SCHERING CORPORATION (US) 1991-01-09 — — EP disclosed
US-4851423-A Pharmaceutically active compounds SCHERING CORPORATION (US) 1989-07-25 — — US disclosed
EP-0274867-A2 Pharmaceutically active compounds SCHERING CORPORATION (US) 1988-07-20 — — EP disclosed
Send feedback